Efficacy of Continuous Peripheral Nerve Block in Patients with Proximal Femur Fracture
DOI:
https://doi.org/10.61581/mjsp.v6i02.372Keywords:
Proximal femur, Peripheral nerve block, Pain management, VAS score, Opioid consumptionAbstract
Objective: To evaluate the efficacy of continuous peripheral nerve block in reducing pain, decreasing opioid consumption, and improving functional outcomes in patients with proximal femur fractures.
Methodology: This prospective study was conducted on 100 patients presenting with proximal femur fractures. Patients received continuous peripheral nerve block using a catheter-based technique. Pain was assessed using the Visual Analog Scale (VAS) at baseline and at 6, 12, 24, and 48 hours post-intervention. Secondary outcomes included opioid consumption, early mobilization, patient satisfaction, and procedure-related complications. Data were analyzed using appropriate statistical methods.
Results: The mean VAS score significantly decreased from 8.5 ± 1.2 pre-block to 2.3 ± 0.7 at 48 hours post-block (p < 0.001). A majority of patients (65%) did not require additional opioid analgesia, while those who required opioids had reduced mean consumption (12.5 ± 4.3 mg morphine equivalents). Early mobilization within 48 hours was achieved in 70% of patients. Patient satisfaction was high, with 75% reporting satisfactory pain control. Complications were minimal, with the majority of patients (82%) experiencing no adverse effects.
Conclusion: Continuous peripheral nerve block is an effective and safe modality for pain management in patients with proximal femur fractures. It significantly reduces pain scores, minimizes opioid requirements, and facilitates early mobilization, thereby improving overall patient outcomes.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Hamid Mehmood, Abdul Ghani

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution (CC-BY) 4.0 License that allows others to share the work with an acknowledgment of the work’s authorship and initial publication in this journal.

